Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05866627
PHASE1

A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to confirm there is no significant effect of gastric pH changes of famotidine on the drug levels of afimetoran in healthy participants.

Official title: A Phase 1 Open-label, 2-Part Crossover Study to Assess the Effect of Acid-reducing Agent Famotidine on the Pharmacokinetics of Afimetoran (BMS-986256) in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2023-07-04

Completion Date

2023-09-29

Last Updated

2026-05-13

Healthy Volunteers

Yes

Interventions

DRUG

Famotidine

Specified dose on specified days

DRUG

Afimetoran

Specified dose on specified days

Locations (1)

Local Institution - 0001

Nottingham, Nottinghamshire, United Kingdom